Cita APA

Tam, C., Allan, J., Siddiqi, T., Kipps, T., Jacobs, R., Opat, S., . . . Ghia, P. (2022). Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: Primary analysis of the CAPTIVATE FD cohort.

Citación estilo Chicago

Tam, CS, et al. Fixed-duration Ibrutinib Plus Venetoclax for First-line Treatment of CLL: Primary Analysis of the CAPTIVATE FD Cohort. 2022.

Cita MLA

Tam, CS, et al. Fixed-duration Ibrutinib Plus Venetoclax for First-line Treatment of CLL: Primary Analysis of the CAPTIVATE FD Cohort. 2022.